Dr. David Kroll returned to the CU Skaggs School of Pharmacy and Pharmaceutical Sciences in January, 2019, as Professor of Pharmacology and Director of Master’s Degree and Certificate Programs in Pharmacy and Pharmaceutical Sciences.
Dr. Kroll began his academic career here in the Department of Pharmaceutical Sciences in 1992 as Assistant Professor of Pharmacology and Toxicology, was promoted to Associate Professor with tenure in 1999, and then conducted sabbatical research during the 2000 calendar year in the Department of Microbiology and Immunology at Duke University in Durham, NC. That year, he became the first School of Pharmacy faculty member to be elected to the system-wide CU President’s Teaching Scholar Program.
Education, Licensure & Certifications
- BS, Toxicology (1985), Philadelphia College of Pharmacy & Science
- PhD, Pharmacology & Therapeutics (1989), University of Florida College of Medicine
- Postdoctoral Fellowship (1990-1992), Endocrinology & Medical Oncology, University of Colorado School of Medicine
- Master of Science in Pharmaceutical Sciences Program
- PhD in Pharmaceutical Sciences Program
- Integrative Health and Medicine (IHM) Certificate Program
- Cancer Pharmacology of Natural Products
- Public Science Communication
- Science and Medical Journalism
Publications and Presentations
Anestopoulos I, Sfakianos A, Franco R, Chlichlia K, Panayiotidis M, Kroll D and Pappa A (2017) A novel role of silibinin as a putative epigenetic modulator in human prostate carcinoma. Molecules 22(1):62.
Sy-Cordero AA, Graf TN, Runyon SP, Wani MC, Kroll DJ, Agarwal R, Brantley SJ, Paine MF, Polyak SJ and Oberlies NH (2013) Enhanced bioactivity of silybin B methylation products. Bioorganic & Medicinal Chemistry 21(3): 742-747.
Oberlies NH and Kroll DJ (2004) Camptothecin and Taxol: Historic achievements in natural products research. Journal of Natural Products 67(2): 129-135.